← Back to All US Stocks

BON Stock Analysis - Bon Natural Life Ltd AI Rating

BON Nasdaq Medicinal Chemicals & Botanical Products E9 CIK: 0001816815
Recently Updated • Analysis: Mar 21, 2026 • SEC Data: 2026-03-21
AI Rating
STRONG SELL
95% Confidence

📊 BON Key Takeaways

Revenue: N/A
Net Margin: N/A
Free Cash Flow: N/A
Current Ratio: N/A
Debt/Equity: N/A
EPS: $0.00
AI Rating: STRONG SELL with 95% confidence

Investment Thesis

Bon Natural Life Ltd presents severe fundamental analysis challenges with virtually no available financial data across income statement, balance sheet, and cash flow metrics. The company appears to have minimal or no reported operational activity, with only 1 metric available out of comprehensive financial data requirements, indicating either a shell company, pre-revenue entity, or serious reporting deficiencies.

BON Strengths

  • -No strengths identified

BON Risks

  • ! Complete absence of revenue and profitability data
  • ! No balance sheet metrics available indicating potential non-reporting status
  • ! Zero cash flow visibility across operating, investing, and financing activities
  • ! No insider trading activity in past 90 days suggesting lack of management confidence
  • ! Impossible to assess financial health, solvency, or operational quality
  • ! Medicinal/botanical sector requires strong fundamentals - none demonstrated here

Key Metrics to Watch

BON Financial Metrics

Revenue
N/A
Net Income
N/A
EPS (Diluted)
$0.00
Free Cash Flow
N/A
Total Assets
N/A
Cash Position
N/A

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

BON Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA N/A
FCF Margin N/A

BON vs Default Sector

How Bon Natural Life Ltd compares to Default sector averages

Net Margin
BON 0.0%
vs
Sector Avg 12.0%
BON Sector
ROE
BON 0.0%
vs
Sector Avg 15.0%
BON Sector
Current Ratio
BON 0.0x
vs
Sector Avg 1.8x
BON Sector
Debt/Equity
BON 0.0x
vs
Sector Avg 0.7x
BON Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

BON Balance Sheet & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A

BON Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

BON SEC Filings

Access official SEC EDGAR filings for Bon Natural Life Ltd (CIK: 0001816815)

Frequently Asked Questions about BON

What is the AI rating for BON?

Bon Natural Life Ltd (BON) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.

What are BON's key strengths?

.

What are the risks of investing in BON?

Complete absence of revenue and profitability data. No balance sheet metrics available indicating potential non-reporting status.

What is BON's revenue and growth?

Bon Natural Life Ltd reported revenue of N/A.

Does BON pay dividends?

Bon Natural Life Ltd does not currently pay dividends.

Where can I find BON SEC filings?

Official SEC filings for Bon Natural Life Ltd (CIK: 0001816815) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is BON's EPS?

Bon Natural Life Ltd has a diluted EPS of $0.00.

How is the AI analysis conducted?

Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 21, 2026 | Data as of: 2026-03-21 | Powered by Claude AI